Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study

Abstract Background Soluble urokinase plasminogen activator receptor is an inflammatory biomarker that may prognosticate cardiovascular outcomes. We sought to determine the associations between soluble urokinase plasminogen activator receptor and established markers of cardiotoxicity in breast cance...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B. Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M. Okwuosa
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-01-01
Serija:	Cardio-Oncology
Teme:	Soluble urokinase Plasminogen Activator Receptor (suPAR) Biomarker Global longitudinal strain (GLS) Echocardiography B-type natriuretic peptide (BNP) Troponin
Online dostop:	https://doi.org/10.1186/s40959-023-00191-0
Oznake:	Označite Brez oznak, prvi označite!